Elevance Health, Inc. (NYSE:ELV) is one of the 20 NYSE Stocks with the Lowest P/E Ratios. Cantor Fitzgerald Reaffirms Its Overweight rating and $400 Price Target on Elevance Health, Inc. (ELV) As 2026 Marketplace rates were set, Cantor Fitzgerald reaffirmed its Overweight rating and$400 price target, drawing attention to Elevance Health, Inc. (NYSE:ELV) on September 16, 2025. According to the company, Elevance Health, Inc. (NYSE:ELV)’s weighted-average estimate is only around 40 basis points away from i ...